<DOC>
	<DOCNO>NCT02120456</DOCNO>
	<brief_summary>Part 1 : To identify Maximum Tolerated Dose ( MTD ) level LEO 43204 daily treatment two consecutive day Part 2 : To evaluate efficacy LEO 43204 two dos daily treatment two consecutive day compare vehicle</brief_summary>
	<brief_title>Safety Efficacy Escalating Doses LEO 43204 Applied Once Daily Two Consecutive Days Approximately 250 cm2 Trunk Extremities Subjects With Actinic Keratosis</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>Part 1 : Subjects 5 20 clinically typical , visible discrete AKs arm Part 2 : Subjects 5 20 clinically typical , visible discrete AKs extremity trunk Location treatment area within 5 cm incompletely heal wound within 5 cm suspect basal cell carcinoma ( BCC ) squamous cell carcinoma ( SCC ) Prior treatment ingenol mebutate gel treatment area Lesions treatment area : atypical clinical appearance ( e.g. , hypertrophic , hyperkeratotic cutaneous horn ) and/or recalcitrant disease ( e.g. , respond cryotherapy two previous occasion )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>